Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Gelteq Stock Price, Quotes and Forecasts | NASDAQ:GELS | Benzinga
Explore Gelteq stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GELS.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Gelteq (GELS) stock?
You can purchase shares of Gelteq (NASDAQ:GELS) through any online brokerage.
Who are Gelteq (GELS) competitors?
Other companies in Gelteq’s space includes: Cingulate (NASDAQ:CING), Cocrystal Pharma (NASDAQ:COCP), Addex Therapeutics (NASDAQ:ADXN), Kiora Pharmaceuticals (NASDAQ:KPRX) and Rani Therapeutics Hldgs (NASDAQ:RANI).
What is the forecast, or price target, for Gelteq (GELS) stock?
There is no analysis for Gelteq to provide a consensus price target.
What is the current price for Gelteq (GELS)?
The stock price for Gelteq (NASDAQ: GELS) is $1.52 last updated May 15, 2025 at 9:06 AM EDT.
Does Gelteq (GELS) pay a dividend?
There are no upcoming dividends for Gelteq.
When is Gelteq (NASDAQ:GELS) reporting earnings?
Gelteq does not have any upcoming earnings scheduled.
Is Gelteq (GELS) going to split?
There is no upcoming split for Gelteq.
What sector and industry does Gelteq (GELS) operate in?
Gelteq is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
